Reorganizing the family Parvoviridae: a revised taxonomy independent of the canonical approach based on host association.


Journal

Archives of virology
ISSN: 1432-8798
Titre abrégé: Arch Virol
Pays: Austria
ID NLM: 7506870

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 14 6 2020
medline: 15 8 2020
entrez: 14 6 2020
Statut: ppublish

Résumé

Parvoviridae, a diverse family of small single-stranded DNA viruses was established in 1975. It was divided into two subfamilies, Parvovirinae and Densovirinae, in 1993 to accommodate parvoviruses that infect vertebrate and invertebrate animals, respectively. This relatively straightforward segregation, using host association as the prime criterion for subfamily-level classification, has recently been challenged by the discovery of divergent, vertebrate-infecting parvoviruses, dubbed "chapparvoviruses", which have proven to be more closely related to viruses in certain Densovirinae genera than to members of the Parvovirinae. Viruses belonging to these genera, namely Brevi-, Hepan- and Penstyldensovirus, are responsible for the unmatched heterogeneity of the subfamily Densovirinae when compared to the Parvovirinae in matters of genome organization, protein sequence homology, and phylogeny. Another genus of Densovirinae, Ambidensovirus, has challenged traditional parvovirus classification, as it includes all newly discovered densoviruses with an ambisense genome organization, which introduces genus-level paraphyly. Lastly, current taxon definition and virus inclusion criteria have significantly limited the classification of certain long-discovered parvoviruses and impedes the classification of some potential family members discovered using high-throughput sequencing methods. Here, we present a new and updated system for parvovirus classification, which includes the introduction of a third subfamily, Hamaparvovirinae, resolves the paraphyly within genus Ambidensovirus, and introduces new genera and species into the subfamily Parvovirinae. These proposals were accepted by the ICTV in 2020 March.

Identifiants

pubmed: 32533329
doi: 10.1007/s00705-020-04632-4
pii: 10.1007/s00705-020-04632-4
doi:

Substances chimiques

Viral Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2133-2146

Subventions

Organisme : Medical Research Council
ID : MC_UU_12014/12
Pays : United Kingdom
Organisme : Hungarian Scientific Research Fund
ID : OTKA NN128309

Auteurs

Judit J Pénzes (JJ)

Center for Structural Biology, Department of Biochemistry and Molecular Biology, The McKnight Brain Institute, University of Florida, Gainesville, FL, USA. judit.penzes@ufl.edu.

Maria Söderlund-Venermo (M)

Department of Virology, University of Helsinki, Helsinki, Finland.

Marta Canuti (M)

Department of Biology, Memorial University of Newfoundland, St John's, NL, Canada.

Anna Maria Eis-Hübinger (AM)

Institute for Virology, University of Bonn Medical Centre, Bonn, Germany.

Joseph Hughes (J)

MRC-University of Glasgow Centre for Virus Research, Glasgow, G61 1QH, UK.

Susan F Cotmore (SF)

Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, 06520-8035, USA.

Balázs Harrach (B)

Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH